The English name is {(2R, 3S, 4R, 5r)-3,4- dihydroxy -5-[(4z)-4- (hydroxyimino)-2-XO-3,4-,dihydro-pyran-1(2h)- yl] oxo. The Chinese name is {(2R, 3S, 4R, 5r)-3,4 bis -5-[(4Z)-4- (hydroxyimino) -2- oxo-3,4- dihydropyrimidine-1(2H)- yl] oxazolidine -2- yl}-.
Monoupiravir was first developed by Emory University in the United States and provided to Merck and Ridgeback Biotherapy for joint development. On June 20, 2022, at 65438 local time, the WHO non-profit drug patent pool (MPP) in Geneva announced that it had signed agreements with 27 generic drug manufacturers around the world.
We will supply high-quality and affordable oral anti-coronavirus pneumonia-19 drug-Monobivir generic drug and its capsules to low-income countries or regions around the world free of charge, so as to promote the affordability and accessibility of oral anti-COVID-19 drugs in low-income countries and help local epidemic prevention and control.